Skip to main content
. Author manuscript; available in PMC: 2007 Jul 23.
Published in final edited form as: Dev Med Child Neurol. 2007 Feb;49(2):123–128. doi: 10.1111/j.1469-8749.2007.00123.x

Table II. Duchenne muscular dystrophy probands.

Test Sample size K–S Z-score Range Mean (SD) t-test
Sentence Structure 16 3–15 9.1 (4.4) 0.78
Concepts and Directions 50 0.96 3–16 7.8 (3.6) 4.74a
Word Class 50 0.60 3–14 8.5 (3.1) 3.56a
Word Structure 16 5–15 8.9 (3.1) 1.47
Formulated Sentences 50 1.0 3–13 7.6 (2.7) 6.59a
Recalling Sentences 50 0.70 3–13 7.6 (2.9) 6.02a
Listening to Paragraphs 50 0.83 3–14 8.8 (3.2) 2.77a
CVLT-C Trials 1–5 50 0.84 28–74 47.0 (11.19) 1.83

Data are presented as scaled scores on Clinical Evaluations of Language Fundamentals, 3rd edition (CELF-3) and T score on California Verbal Learning Test – Children’s Version (CVLT-C). Note that data for two subtests, Sentence Structure and Word Structure, do not represent full samples because scaled scores were not available for all participants because of age constraints for score conversion. K–S, Kolmogorov–Smirnov test of normal distribution. One-sample t-tests were run comparing with expected values of 10 on CELF-3 tests and 50 on CVLT-C.

a

Significant finding (p<0.05).